HMD
COM:HERA-MED
Hera Med
- Stock
Last Close
0.02
22/11 04:57
Market Cap
15.20M
Beta: -
Volume Today
1.98M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
---|---|---|---|---|---|---|---|---|---|
average inventory | 40.91K - | 81.70K - | 63.68K 22.05% | 78.88K 23.87% | 129.94K 64.73% | 307.17K 136.39% | |||
average payables | 17.98K - | 463.43K - | 477.44K 3.02% | 595.75K 24.78% | 626.84K 5.22% | 757.10K 20.78% | |||
average receivables | 58.23K - | 156.15K - | 184.44K 18.12% | 237.97K 29.02% | 248.56K 4.45% | 378.15K 52.14% | |||
book value per share | 0.01 - | 0.00 78.36% | 0.05 1,663.68% | 0.03 45.59% | 0.01 - | 0.00 81.10% | |||
capex per share | -0.00 - | -0.01 165.68% | -0.00 82.73% | -0.00 15.17% | -0.00 - | -0.00 99.76% | |||
capex to depreciation | -61.40 - | -120.14 95.67% | -0.60 99.50% | -1.93 - | -0.00 99.84% | ||||
capex to operating cash flow | 0.21 - | 1.54 616.66% | 0.10 93.45% | 0.08 24.57% | 0.02 72.42% | 0.03 26.11% | 0.11 317.45% | 0.00 99.67% | |
capex to revenue | -2.31 - | -1.43 38.19% | -1.48 3.76% | -0.99 33.34% | -3.16 220.08% | -0.00 99.89% | |||
cash per share | 0.02 - | 0.00 96.85% | 0.05 7,205.34% | 0.02 49.85% | 0.01 - | 0.00 67.97% | |||
days of inventory on hand | 3.27K - | 286.70 91.23% | 190.03 33.72% | 800.59 321.29% | 764.52 4.50% | 799.14 4.53% | 145.52 81.79% | ||
days payables outstanding | 1.05K - | 664.27 36.69% | 1.28K 92.84% | 1.49K 16.54% | 5.76K 285.94% | 5.99K 3.91% | 2.61K 56.33% | 482.55 81.54% | |
days sales outstanding | 838.09 - | 339.20 59.53% | 2.16K 536.57% | 1.02K 52.76% | 425.08 58.33% | 302.94 28.73% | |||
debt to assets | 0.12 - | 0.24 92.31% | 0.03 85.84% | 0.07 97.54% | 0.06 10.31% | 0.74 1,141.44% | 0.04 94.25% | 0.09 106.01% | |
debt to equity | 0.25 - | 1.48 500.11% | 0.04 97.08% | 0.10 134.20% | 0.10 5.00% | -32.25 33,725.74% | 0.06 100.19% | 0.38 512.15% | |
dividend yield | |||||||||
earnings yield | -0.17 - | -0.06 63.97% | -0.27 339.01% | -0.23 12.73% | -0.36 - | -1.07 193.76% | |||
enterprise value | 15.21M - | 17.11M 12.48% | 10.16M 40.63% | 12.36M 21.65% | -1.71M 113.86% | -140.91K 91.77% | 15.78M 11,298.79% | 5.56M 64.78% | |
enterprise value over ebitda | -5.62 - | -20.62 266.91% | -3.53 82.87% | -4.12 16.71% | 0.55 113.44% | 0.04 93.07% | -5.67 14,849.86% | -0.92 83.69% | |
ev to operating cash flow | -7.90 - | -23.98 203.42% | -5.75 76.01% | -4.53 21.21% | 0.61 113.55% | 0.04 92.90% | -2.52 5,881.34% | -0.97 61.45% | |
ev to sales | 131.63 - | 85.00 35.43% | -43.33 150.98% | -1.63 96.25% | 72.09 4,532.86% | 9.16 87.30% | |||
free cash flow per share | -0.03 - | -0.02 22.55% | -0.02 14.35% | -0.03 49.25% | -0.03 - | -0.02 34.91% | |||
free cash flow yield | -0.14 - | -0.11 22.55% | -0.14 28.64% | -0.21 49.25% | -0.38 - | -0.90 135.92% | |||
graham net net | 0.01 - | -0.01 264.49% | 0.03 358.67% | 0.01 68.72% | 0.01 - | -0.00 132.13% | |||
graham number | 0.09 - | 0.03 72.08% | 0.22 729.60% | 0.15 31.09% | 0.10 - | 0.04 60.86% | |||
income quality | 0.67 - | 0.69 2.89% | 0.47 32.45% | 0.95 - | 0.84 10.86% | ||||
intangibles to total assets | 0.16 - | 0.89 439.27% | 0.22 75.68% | 0.32 48.56% | 0.30 5.81% | 0.15 51.66% | 0.25 70.99% | 0 100% | |
interest coverage | -19.39 - | -4.43 77.14% | -3.22 27.29% | -434.84 13,385.63% | -324.32 25.42% | -2.35 99.27% | -1.81 23.15% | -49.45 2,634.44% | |
interest debt per share | 0.00 - | 0.01 31.57% | 0.01 99.27% | 0.00 77.22% | 0.01 - | 0.00 83.67% | |||
inventory turnover | 0.11 - | 1.27 1,040.69% | 1.92 50.87% | 0.46 76.26% | 0.48 4.72% | 0.46 4.33% | 2.51 449.15% | ||
invested capital | 0.25 - | 1.48 500.11% | 0.04 97.08% | 0.10 134.20% | 0.10 5.00% | -32.25 33,725.74% | 0.06 100.19% | 0.38 512.15% | |
market cap | 16.78M - | 16.78M 0% | 14.00M 16.54% | 14.16M 1.12% | 18.22M - | 6.36M 65.11% | |||
net current asset value | 785.80K - | -1.20M 252.45% | 3.13M 361.39% | 1.14M 63.52% | 1.01M 11.50% | -805.33K 179.66% | 1.75M 317.05% | -342.73K 119.61% | |
net debt to ebitda | 0.58 - | -0.40 168.26% | 1.34 437.88% | 0.60 55.00% | 0.55 7.98% | 0.04 93.07% | 0.88 2,179.20% | 0.13 84.82% | |
net income per share | -0.03 - | -0.01 63.97% | -0.04 290.23% | -0.04 12.73% | -0.03 - | -0.03 18.95% | |||
operating cash flow per share | -0.02 - | -0.01 62.93% | -0.02 163.60% | -0.03 52.68% | -0.03 - | -0.02 27.75% | |||
payables turnover | 0.35 - | 0.55 57.95% | 0.28 48.14% | 0.24 14.19% | 0.06 74.09% | 0.06 3.76% | 0.14 129.00% | 0.76 441.77% | |
receivables turnover | 0.44 - | 1.08 147.08% | 0.17 84.29% | 0.36 111.68% | 0.86 139.97% | 1.20 40.32% | |||
research and ddevelopement to revenue | 8.79 - | 6.35 27.80% | 29.88 370.79% | 17.47 41.54% | 3.46 80.18% | 3.49 0.75% | |||
return on tangible assets | -1.42 - | -5.66 297.70% | -0.87 84.64% | -1.36 56.17% | -1.55 14.26% | -1.88 21.44% | -2.12 12.65% | -2.30 8.27% | |
revenue per share | 0.00 - | 0.00 86.31% | 0.00 - | 0.00 119.26% | |||||
roe | -2.36 - | -3.92 66.50% | -0.87 77.87% | -1.39 60.39% | -1.73 24.34% | 69.66 4,125.00% | -2.31 103.32% | -9.92 328.82% | |
roic | -1.80 - | -1.29 28.15% | -0.79 39.19% | -1.23 56.29% | -1.57 27.92% | -1.54 2.05% | -1.40 8.84% | -7.07 404.21% | |
sales general and administrative to revenue | 23.54 - | 8.50 63.89% | 29.33 245.13% | 20.02 31.74% | 7.80 61.05% | ||||
shareholders equity per share | 0.01 - | 0.00 78.36% | 0.05 1,663.68% | 0.03 45.59% | 0.01 - | 0.00 81.10% | |||
stock based compensation to revenue | |||||||||
tangible asset value | 816.18K - | -1.18M 244.11% | 3.15M 367.54% | 1.23M 60.86% | 1.03M 16.14% | -776.34K 175.16% | 1.82M 334.87% | 683.96K 62.49% | |
tangible book value per share | 0.01 - | -0.01 244.11% | 0.04 384.95% | 0.01 61.29% | 0.01 - | 0.00 70.34% | |||
working capital | 1.43M - | -313.24K 121.94% | 3.82M 1,318.22% | 1.82M 52.33% | 1.69M 7.03% | -256.11K 115.14% | 2.25M 979.64% | 419.47K 81.38% |
All numbers in (except ratios and percentages)